Mitsubishi Tanabe Pharma Europe Ltd www.mt-pharma-eu.com

5.2

Unique link for this page:

https://sitemorse.com/sa/157398/1/1c340986

Purchase the detailed results View Priorities (FREE)

INDEX	Rank	First	Last	Climber	Faller
2019 Q1	42nd	Cytogen	Taro Pharmaceutical Industries	Baxter International (+138)	BTG International (-174)
2018 Q4	36th	Cytogen	Taro Pharmaceutical Industries	Advaxis (+128)	Baxter International (-112)
2018 Q3	39th	Cytogen	Taro Pharmaceutical Industries	Medivir Group (+121)	Akorn (-102)
2018 Q2	31st	Cytogen	Perrigo UK	Sanofi (+175)	Advaxis (-106)
2018 Q1	37th	HG Capital Trust	Perrigo UK	Genus (+153)	Sawai Pharmaceutical (-131)
2017 Q4	23rd	HG Capital Trust	Cerus	Zandu (+104)	Aptalis Pharma (-101)
2017 Q3	36th	Servier UK	Perrigo UK	Leo Pharma UK (+86)	Chiesi (-125)
2017 Q2	42nd	Servier UK	Myriad Genetics	Bosnalijek (+196)	Anika Therapeutics (-175)
2017 Q1	25th	Servier UK	Sinovac Biotech	Regeneron (+130)	Bosnalijek (-112)
2016 Q4	12th	Taisho Pharmaceutical	Sinovac Biotech	MannKind Corporation (+172)	CinnaGen (-201)
2016 Q3	22nd	Wockhardt	Sinovac Biotech	Biota (+134)	Daiichi-Sankyo UK (-98)
2016 Q2	24th	ProStrakan Group	Santen Europe	Julphar (+185)	Alfa Wassermann (-131)
2016 Q1	14th	Neurocrine Biosciences	Enzon Pharmaceuticals	Cipla (+157)	Laboratoires Thea (-127)
2015 Q4	14th	Anika Therapeutics	Sinopharm	Baxter International (+168)	ImmunoGen (-123)
2015 Q3	13th	Anika Therapeutics	Beximco Pharmaceuticals	Dr Reddy's (+150)	Progenics Pharmaceuticals (-75)
2015 Q2	23rd	Actelion	Sinopharm	Anika Therapeutics (+187)	Mylan (-157)
2015 Q1	23rd	Biogen Idec	Sinopharm	NPS Pharmaceuticals (+133)	Hospira UK (-149)
2014 Q4	26th	Biogen Idec	Sinopharm	Bial Portela (+117)	Genus (-124)
2014 Q3	28th	Biogen Idec	Sinopharm	Mitsubishi Tanabe Pharma Europe Ltd (+207)	Questcor (-210)
2014 Q2	235th	Cytogen	Merck Sharp & Dohme, MSD	Medivation (+122)	Idenix Pharmaceuticals (-222)
2014 Q1	193rd	Idenix Pharmaceuticals	Sinopharm	Advaxis (+167)	Celgene (-114)
2013 Q4	142nd	Idenix Pharmaceuticals	Sinopharm	Intas Biopharmaceuticals (+132)	Sawai Pharmaceutical (-160)
2013 Q3	152nd	Idenix Pharmaceuticals	Sinopharm	ImmunoGen (+164)	ARIAD Pharmaceuticals (-140)
2013 Q2	147th	Galenica AG	Sinopharm	Ferozsons Laboratories (+54)	Hospira (-180)